Concord Investment Counsel Inc. Ishares Biotechnology ETF Transaction History
Concord Investment Counsel Inc.
- $277 Billion
- Q1 2024
A detailed history of Concord Investment Counsel Inc. transactions in Ishares Biotechnology ETF stock. As of the latest transaction made, Concord Investment Counsel Inc. holds 32,975 shares of IBB stock, worth $4.45 Million. This represents 1.63% of its overall portfolio holdings.
Number of Shares
32,975Holding current value
$4.45 Million% of portfolio
1.63%Shares
1 transactions
Others Institutions Holding IBB
# of Institutions
986Shares Held
37.8MCall Options Held
1.81MPut Options Held
8.71M-
Bank Of America Corp Charlotte, NC7.63MShares$1.03 Billion0.1% of portfolio
-
Goldman Sachs Group Inc New York, NY3.21MShares$434 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.7MShares$365 Million0.03% of portfolio
-
Citigroup Inc2.59MShares$349 Million0.24% of portfolio
-
Jpmorgan Chase & CO New York, NY1.61MShares$217 Million0.02% of portfolio